Lazard Asset Management’s Boston Scientific BSX Stock Holding History

Lazard Asset Management’s Portfolio BSX Stock Details BSX Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$712M	Buy	6,632,760 +372,200	+6%	+$40M	0.98%	16
2025 Q1	$632M	Sell	6,260,560 -217,673	-3%	-$22M	0.97%	21
2024 Q4	$579M	Sell	6,478,233 -775,800	-11%	-$69.3M	0.85%	28
2024 Q3	$608M	Sell	7,254,033 -259,481	-3%	-$21.7M	0.81%	35
2024 Q2	$579M	Buy	7,513,514 +83,675	+1%	+$6.44M	0.73%	40
2024 Q1	$509M	Sell	7,429,839 -1,398,409	-16%	-$95.8M	0.62%	43
2023 Q4	$510M	Sell	8,828,248 -78,889	-0.9%	-$4.56M	0.65%	41
2023 Q3	$470M	Sell	8,907,137 -285,441	-3%	-$15.1M	0.64%	39
2023 Q2	$497M	Sell	9,192,578 -2,226,793	-20%	-$120M	0.61%	44
2023 Q1	$571M	Sell	11,419,371 -1,286,098	-10%	-$64.3M	0.75%	32
2022 Q4	$588M	Buy	12,705,469 +165,750	+1%	+$7.67M	0.81%	27
2022 Q3	$486M	Sell	12,539,719 -113,333	-0.9%	-$4.39M	0.71%	34
2022 Q2	$472M	Buy	12,653,052 +2,416,974	+24%	+$90.1M	0.64%	39
2022 Q1	$453M	Buy	10,236,078 +336,929	+3%	+$14.9M	0.53%	44
2021 Q4	$421M	Buy	9,899,149 +176,763	+2%	+$7.51M	0.45%	55
2021 Q3	$422M	Buy	9,722,386 +14,004	+0.1%	+$608K	0.48%	51
2021 Q2	$415M	Sell	9,708,382 -123,618	-1%	-$5.29M	0.47%	51
2021 Q1	$380M	Buy	9,832,000 +276,703	+3%	+$10.7M	0.46%	50
2020 Q4	$344M	Buy	9,555,297 +919,471	+11%	+$33.1M	0.43%	57
2020 Q3	$330M	Buy	8,635,826 +2,856,714	+49%	+$109M	0.46%	56
2020 Q2	$203M	Buy	5,779,112 +4,147,408	+254%	+$146M	0.31%	75
2020 Q1	$53.2M	Sell	1,631,704 -96,373	-6%	-$3.14M	0.1%	161
2019 Q4	$78.1M	Sell	1,728,077 -168,682	-9%	-$7.63M	0.11%	149
2019 Q3	$77.2M	Sell	1,896,759 -29,955	-2%	-$1.22M	0.13%	140
2019 Q2	$82.8M	Buy	1,926,714 +726,934	+61%	+$31.2M	0.13%	131
2019 Q1	$46M	Sell	1,199,780 -90,416	-7%	-$3.47M	0.08%	181
2018 Q4	$45.6M	Buy	1,290,196 +1,146,523	+798%	+$40.5M	0.08%	164
2018 Q3	$5.53M	Sell	143,673 -18,948	-12%	-$729K	0.01%	556
2018 Q2	$5.32M	Buy	+162,621	New	+$5.32M	0.01%	552